Novacta Biosystems
Welwyn Garden City
About Novacta Biosystems
Leveraging the extensive knowledge of GSK's Biotransformation and Natural Products scientific team, Novacta Biosystems Ltd was founded in 2003. In the following 5 years, Novacta successfully adopted a dual business model, whereby it developed a biocatalysis and microbial pathway engineering service business, that supported its efforts to build an infectious disease therapeutic pipeline.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $30.8M
- Last round: Series Unknown (Jul 2009)
- Website: novactabio.com
- Phone: +44 1707356131
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/novacta-biosystems-2436544 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.